Business
First Patient Dosed for Phase 1, Pain Indication IRX211
First Patient Dosed for Phase 1, Pain Indication IRX211
About this update from Nexalis Therapeutics Limited
[{"type":"text","content":"Nexalis Therapeutics Limited has released a press release. View Attachment","length":247,"tagName":"div"}]